enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
3.290
+0.110 (3.46%)
Jan 17, 2025, 4:00 PM EST - Market closed
enVVeno Medical Employees
enVVeno Medical had 31 employees as of December 31, 2023. The number of employees increased by 1 or 3.33% compared to the previous year.
Employees
31
Change (1Y)
1
Growth (1Y)
3.33%
Revenue / Employee
n/a
Profits / Employee
-$685,129
Market Cap
57.69M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
NVNO News
- 5 weeks ago - enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe - Accesswire
- 7 weeks ago - enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website - Accesswire
- 2 months ago - enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium - Accesswire
- 2 months ago - enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval - Accesswire
- 3 years ago - Hancock Jaffe to Participate in the Duologue Series Virtual Webinar Hosted by Ladenburg Thalmann - Accesswire
- 3 years ago - Hancock Jaffe To Rebrand As enVVeno Medical - Benzinga
- 3 years ago - Hancock Jaffe Announces Corporate Rebranding to Reflect Prioritization of its Development Pipeline on Venous Disease Programs - Accesswire
- 3 years ago - Hancock Jaffe to Host Corporate Update Conference Call and Webcast on September 21, 2021 - Accesswire